Read more

December 02, 2021
7 min watch
Save

VIDEO: Practice guidelines for cardiometabolic disorders developed by multispecialty group

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, talks with Vivian A. Fonseca, MD, about new multispecialty practice recommendations developed by the Diabetes, CardioRenal Metabolic Diseases Task Force.

Handelsman is medical director and principal investigator of the Metabolic Institute of America in Tarzana, California, and chair of WCIRDC. Fonseca is professor of medicine, chief of the endocrinology section and vice dean for clinical research at Tulane University in New Orleans.

“Medications that were in the hands of a diabetologist or endocrinologist have become a medication for a cardiologist and a medication for a nephrologist — it’s a whole new different dimension,” Handlesman said.

The task force of experts in cardiology, endocrinology and nephrology met during the summer to discuss practices for managing diabetes with cardiorenal metabolic diseases. The resulting recommendations covering 18 interrelated cardiometabolic disorders are for use by primary care physicians and specialists.

The recommendations will be presented at WCIRDC on December 3 and simultaneously published in the Journal of Diabetes and Its Complications, of which Fonseca is editor-in-chief.